Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study-Reference-Cited by-同舟云学术

Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Published:2009-01 Issue:6 Volume:18 Page:348-361
ISSN:0803-7051
Container-title:Blood Pressure
language:en
Short-container-title:Blood Pressure

Author:

Kjeldsen Sverre E.,Devereux Richard B.,Hille Darcy A.,Lyle Paulette A.,Dahlöf Björn,Julius Stevo,Edelman Jonathan M.,Snapinn Steven M.,de Faire Ulf,Fyhrquist Frej,Ibsen Hans,Lederballe-Pedersen Ole,Lindholm Lars H.,Nieminen Markku S.,Omvik Per,Oparil Suzanne,Wedel Hans,

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/08037050903460590

Reference28 articles.

1. H35 Baseline characteristics of the life (Losartan intervention for endpoint reduction) in hypertension study

2. Characteristics of 9194 Patients With Left Ventricular Hypertrophy

3. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

4. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

5. An updated coronary risk profile. A statement for health professionals.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction models for cardiovascular disease risk in the hypertensive population: a systematic review;Journal of Hypertension;2020-04-03

2. Hypertension Control Rate Should be Defined Consistently and Used to Motivate Action to Improve;High Blood Pressure & Cardiovascular Prevention;2019-11-19

3. Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: An “old dog playing good tricks”;The Journal of Clinical Hypertension;2018-06-15

4. Effects of losartan on vasomotor function and canonical transient receptor potential channels in the aortas of sinoaortic denervation rats;Clinical and Experimental Hypertension;2017-10-26

5. Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study);The American Journal of Cardiology;2017-06